52817-243 : Lamotrigine Extended Release Extended Release 200 mg Oral Tablet


NDC52817-243
Labeler: Trupharma, LLC
Product Type: Human Prescription Drug
Drug Name:  Lamotrigine Extended Release
Dosage Form: Oral Tablet
Application #: ANDA202887
Rev. Date: 


Appearance:


Markings: H011
Shapes:  Round
Colors:  Blue
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 52817-243-30: 30 TABLET IN 1 BOTTLE (52817‑243‑30)

Active Ingredients:

  • Lamotrigine

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Hypromellose, Unspecified
  • Lactose Monohydrate
  • Magnesium Stearate
  • Mannitol
  • Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type a
  • Polyethylene Glycol, Unspecified
  • Polyvinyl Alcohol, Unspecified
  • Talc
  • Titanium Dioxide
  • Triethyl Citrate
  • Ferrosoferric Oxide
  • Fd&c Blue No. 1

Pharmaceutical Classes:

  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]
  • Mood Stabilizer [EPC]

Related Products:

Based on records with the same trade name.
  • 52817-240 Lamotrigine Extended Release Extended Release 25 mg Oral Tablet by Trupharma, LLC
  • 52817-241 Lamotrigine Extended Release Extended Release 50 mg Oral Tablet by Trupharma, LLC
  • 52817-242 Lamotrigine Extended Release Extended Release 100 mg Oral Tablet by Trupharma, LLC
  • 49884-561 Lamotrigine 25 mg 24 Hr Extended Release Tablet by Par Pharmaceutical Inc.
  • 49884-562 Lamotrigine 50 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
  • 49884-563 Lamotrigine 100 mg 24 Hr Extended Release Tablet by Par Pharmaceutical Inc.
  • 49884-564 Lamotrigine 200 mg 24 Hr Extended Release Tablet by Par Pharmaceutical Inc.
  • 49884-604 Lamotrigine 250 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
  • 49884-605 Lamotrigine 300 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
  • 63629-7020 Lamotrigine Extended Release Extended Release 300 mg Oral Tablet by Bryant Ranch Prepack
  • 70518-0489 Lamotrigine Extended Release Extended Release 50 mg Oral Tablet by Remedyrepack Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 52817-243 QR Code

< Prev: 52817-242Next: 52817-250 >

Related Discussions:

Lamotrigine 200 mg tab by northstar
Been on generic by Northstar for over a year then this last June 2013 I filled my rx again and within 48 hours I went th... 8 replies
Lamotrigine Drug Information
Would like to know what this med is used for?? ## triangular shape lamotrigine with 93 on front and 463 on back - How ma... 7 replies
lamotrigine cough and vomiting
I have bipolar disorder and have been on almost everything for it, was taking depakote and Saphris which worked great bu... 3 replies
lamotrigine and vistaril
My girlfriend just got prescribed these 2 meds together for bipolar disorder. Is this safe? The vistaril is 50mg twice a... 2 replies
lamotrigine 100 mg
round white tablet imprint zc80 ## I want to verify that the pills in this bottle are Lamotrigine 100 Mg. The pills are ... 2 replies
Lamotrigine side effects
I have been taking this medicine for the last 9 months. Whenever my dose is increased above 100mg i am facing body aches... 2 replies
Lamotrigine split dose
Can Lamotrigine 150 be cut in quarters to lower the dose? I have many 150mg left and would like to use them up if I can ... 1 reply
Lamotrigine - feelings of insecurity and despair
Pending a formal diagnosis (one psychiatrist felt I was low-level bipolar, my current psychiatrist feels I have a severe... 1 reply
lamotrigine is this an opioid
I need to know if this medication is an opioid ## Hello, Twiggy! How are you? No, the FDA classifies Lamotrigine as an a... 1 reply
lamotrigine 100mg
pink 463 ## Does it also have a 93 on it or the word TEVA? The newer tablets will have Teva on it, since they are gettin... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.